Cluster Randomized Trial of Stepped Care Intervention vs. Treatment as Usual for Patients With Depression
SCM
Effektivität Und Effizienz Von Behandlungspfaden für Patienten Mit Depressiven Erkrankungen: Stepped Care Als Ansatz für Ein Leitliniengerechtes Und Integriertes Versorgungsmanagement
1 other identifier
interventional
737
1 country
1
Brief Summary
The main aim of the project is the implementation and evaluation of a stepped care model (SCM) for patients with depression with 6 treatment options of varying intensity and setting, including innovative technologies (e-mental health, telephone-based psychotherapy). Within this complex intervention, patients are treated by a multiprofessional network of health care providers in Hamburg, Germany. The study compares the SCM condition (intervention group) to a control group receiving treatment as usual (cluster randomization on the level of participating general practitioners). It is expected that the SCM condition will show better results regarding reduction of mental symptoms, improvement of quality of life, more efficient access to care and better cost-benefit ratio.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable depression
Started Sep 2012
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 12, 2012
CompletedFirst Posted
Study publicly available on registry
November 22, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedJuly 13, 2015
July 1, 2015
2.5 years
November 12, 2012
July 10, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in depression severity (PHQ-D-9)
Change in patient-rated depression symptom severity: Patient Health Questionnaire 9, German version (PHQ-D-9; Löwe, Zipfel \& Herzog, 2002)
Baseline, 3 months, 6 months, 12 months
Secondary Outcomes (11)
Cost-benefit ratio (QALYs)
Baseline, 6 months, 12 months
Response/Remission/Relapse (PHQ-D-9)
Baseline, 3 months, 6 months, 12 months
Quality of life (EQ-5D)
Baseline, 3 months, 6 months, 12 months
Quality of life (SF-12)
Baseline, 3 months, 6 months, 9 months
Health service utilization and medication consumption
Baseline, 6 months, 12 months
- +6 more secondary outcomes
Study Arms (2)
Stepped care intervention (SCM)
EXPERIMENTALPatients within the stepped care intervention are screened by general physician using the PHQ-9 (inclusion criterion: \>4 points) and diagnosed according to International Classification of Diseases (ICD-10) criteria. Patients receive differentially intensive treatment according to depression severity. Patients with mild depression receive: Step I: Active monitoring or Step II: II.a. Bibliotherapy or II.b. Online self-help ("Deprexis®") or II+: Telephone-based psychotherapy Patients with moderate depression receive: Step III: III.a. Outpatient psychotherapy or III.b. Psychopharmacological treatment Patients with severe depression receive: Step IV: Combined psychotherapy and psychopharmacological treatment, optionally in inpatient setting.
Control group: treatment as usual
ACTIVE COMPARATORPatients in the control group are screened by their general physician using the PHQ-D-9 depression scale. Patients included in the study then receive treatment as usual from general physician or other health service providers.
Interventions
General physician performs monitoring every 2 weeks using the PHQ-9 depression scale.
Patient works with self-help book "Selbsthilfe bei Depressionen" (Görlitz, 2010) under general physician's supervision.
Patient works with online self-help program "Deprexis" under general physician's supervision.
Patient receives outpatient psychodynamic or cognitive-behavioural psychotherapy from a psychotherapist participating in the network.
Patient receives treatment from psychiatrist or general physician participating in the network, this includes psychopharmacotherapy. Treatment takes place within routine care, thus psychiatrists or general physicians individually determine the type of medication and are committed to follow the recommendations of the German S3-Guideline/National Disease Management Guideline for Unipolar Depression.
Patient receives psychotherapy combined with psychopharmacological treatment, if necessary in inpatient setting.
Eligibility Criteria
You may qualify if:
- \>4 points on PHQ-D-9 depression scale
- sufficient knowledge of German language
- health situation that allows questionnaire completion
You may not qualify if:
- insufficient knowledge of German language
- health situation not allowing questionnaire completion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Psychosocial Medicine, Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf
Hamburg, Hamburg, 20246, Germany
Related Publications (2)
Brettschneider C, Heddaeus D, Steinmann M, Harter M, Watzke B, Konig HH. Cost-effectiveness of guideline-based stepped and collaborative care versus treatment as usual for patients with depression - a cluster-randomized trial. BMC Psychiatry. 2020 Aug 28;20(1):427. doi: 10.1186/s12888-020-02829-0.
PMID: 32859177DERIVEDWatzke B, Heddaeus D, Steinmann M, Konig HH, Wegscheider K, Schulz H, Harter M. Effectiveness and cost-effectiveness of a guideline-based stepped care model for patients with depression: study protocol of a cluster-randomized controlled trial in routine care. BMC Psychiatry. 2014 Aug 20;14:230. doi: 10.1186/s12888-014-0230-y.
PMID: 25182269DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Birgit Watzke, Prof. Dr.
Centre for Psychosocial Medicine, Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
- STUDY DIRECTOR
Martin Härter, Prof. Dr. Dr.
Centre for Psychosocial Medicine, Department of Medical Psychology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 12, 2012
First Posted
November 22, 2012
Study Start
September 1, 2012
Primary Completion
March 1, 2015
Study Completion
May 1, 2015
Last Updated
July 13, 2015
Record last verified: 2015-07